Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma

Table 1

Details of TACE interval and TACE delay >90 days between the prelockdown and lockdown groups.

Procedure	Factors	Prelockdown group	Lockdown group	value
First TACE	First TACE interval (days), mean ± SD	46.5 ± 21.6 (n = 47)	51.2 ± 28.3 (n = 48)	0.826
	First TACE delay > 90 days, n (%)	2 (4.3)	7 (14.6)	0.159
Repeated TACE	Repeated TACE interval (days), mean ± SD	63.5 ± 25.2 (n = 87)	76.7 ± 32.9 (n = 58)	0.007^∗
	Repeated TACE delay > 90 days, n (%)	10 (11.5)	13 (22.4)	0.126

TACE, transarterial chemoembolization; SD, standard deviation.